CLINICAL_TRIALS
research
· 2026-03-27
Clinical Trial Update: A Dose-exploration Study of EDP167 in HoFH [Phase 2]
Summary
A Phase 2 dose-exploration trial of EDP167 for homozygous familial hypercholesterolemia is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eddingpharm (Zhuhai) Co., Ltd. | Conditions: Homozygous Familial Hypercholesterolemia (HoFH) | Phase 2 | Status: RECRUITING